238 related articles for article (PubMed ID: 11401583)
1. Heparin antagonists are potent inhibitors of mast cell tryptase.
Hallgren J; Estrada S; Karlson U; Alving K; Pejler G
Biochemistry; 2001 Jun; 40(24):7342-9. PubMed ID: 11401583
[TBL] [Abstract][Full Text] [Related]
2. Polycationic peptides as inhibitors of mast cell serine proteases.
Lundequist A; Juliano MA; Juliano L; Pejler G
Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin.
Hallgren J; Spillmann D; Pejler G
J Biol Chem; 2001 Nov; 276(46):42774-81. PubMed ID: 11533057
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of tryptase for the treatment of mast cell-mediated diseases.
Rice KD; Tanaka RD; Katz BA; Numerof RP; Moore WR
Curr Pharm Des; 1998 Oct; 4(5):381-96. PubMed ID: 10197050
[TBL] [Abstract][Full Text] [Related]
5. Histidines are critical for heparin-dependent activation of mast cell tryptase.
Hallgren J; Bäckström S; Estrada S; Thuveson M; Pejler G
J Immunol; 2004 Aug; 173(3):1868-75. PubMed ID: 15265919
[TBL] [Abstract][Full Text] [Related]
6. Formation of active monomers from tetrameric human beta-tryptase.
Fajardo I; Pejler G
Biochem J; 2003 Feb; 369(Pt 3):603-10. PubMed ID: 12387726
[TBL] [Abstract][Full Text] [Related]
7. Mast cell tryptase beta as a target in allergic inflammation: an evolving story.
Sommerhoff CP; Schaschke N
Curr Pharm Des; 2007; 13(3):313-32. PubMed ID: 17313363
[TBL] [Abstract][Full Text] [Related]
8. Mechanism for activation of mouse mast cell tryptase: dependence on heparin and acidic pH for formation of active tetramers of mouse mast cell protease 6.
Hallgren J; Karlson U; Poorafshar M; Hellman L; Pejler G
Biochemistry; 2000 Oct; 39(42):13068-77. PubMed ID: 11041873
[TBL] [Abstract][Full Text] [Related]
9. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation.
He S; Walls AF
Eur J Pharmacol; 1997 Jun; 328(1):89-97. PubMed ID: 9203574
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G.
He S; McEuen AR; Blewett SA; Li P; Buckley MG; Leufkens P; Walls AF
Biochem Pharmacol; 2003 Mar; 65(6):1007-15. PubMed ID: 12623133
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers.
Addington AK; Johnson DA
Biochemistry; 1996 Oct; 35(42):13511-8. PubMed ID: 8885830
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.
He S; Aslam A; Gaça MD; He Y; Buckley MG; Hollenberg MD; Walls AF
J Pharmacol Exp Ther; 2004 Apr; 309(1):119-26. PubMed ID: 14722328
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of dipeptidyl peptidase I in the human mast cell line HMC-1: blocked activation of tryptase, but not of the predominant chymotryptic activity.
Sheth PD; Pedersen J; Walls AF; McEuen AR
Biochem Pharmacol; 2003 Dec; 66(11):2251-62. PubMed ID: 14609749
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase.
Cregar L; Elrod KC; Putnam D; Moore WR
Arch Biochem Biophys; 1999 Jun; 366(1):125-30. PubMed ID: 10334872
[TBL] [Abstract][Full Text] [Related]
15. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors.
He S; Gaça MD; Walls AF
Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285
[TBL] [Abstract][Full Text] [Related]
16. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.
He S; Gaça MD; Walls AF
J Pharmacol Exp Ther; 1998 Jul; 286(1):289-97. PubMed ID: 9655871
[TBL] [Abstract][Full Text] [Related]
17. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
Caughey GH; Raymond WW; Bacci E; Lombardy RJ; Tidwell RR
J Pharmacol Exp Ther; 1993 Feb; 264(2):676-82. PubMed ID: 8437115
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.
Hallgren J; Lindahl S; Pejler G
J Mol Biol; 2005 Jan; 345(1):129-39. PubMed ID: 15567416
[TBL] [Abstract][Full Text] [Related]
19. Active monomers of human beta-tryptase have expanded substrate specificities.
Fukuoka Y; Schwartz LB
Int Immunopharmacol; 2007 Dec; 7(14):1900-8. PubMed ID: 18039527
[TBL] [Abstract][Full Text] [Related]
20. Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization.
Chen Y; Shiota M; Ohuchi M; Towatari T; Tashiro J; Murakami M; Yano M; Yang B; Kido H
Eur J Biochem; 2000 Jun; 267(11):3189-97. PubMed ID: 10824103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
